HOME >> MEDICINE >> NEWS
Diuretics best initial therapy for both black and nonblack patients in treating high blood pressure

Thiazide-type diuretics remain the drugs of choice for initial therapy of high blood pressure in both black and nonblack patients, according to a study in the April 6 issue of JAMA.

Cardiovascular disease (CVD) has become the leading cause of illness and death worldwide, and elevated blood pressure (BP) is a leading contributor to this phenomenon, according to background information in the article. The population of blacks with hypertension has the highest rate of illness and death from hypertension of any population group in the United States and is among the highest in the world. Death related to hypertension and the risk of end-stage renal disease (ESRD), coronary heart disease (CHD), heart failure (HF), and stroke are increased in the black compared with the white population in the United States. There is little cardiovascular outcome data for blacks with hypertension treated with the common therapies of angiotensin-converting enzyme (ACE) inhibitors or calcium channel blockers (CCBs).

Jackson T. Wright, Jr., M.D., Ph.D., of Case Western Reserve University, Cleveland, and colleagues analyzed data from a subgroup of ALLHAT, a randomized, double-blind, clinical trial which compared high blood pressure medications. The researchers conducted this analysis to determine whether an ACE inhibitor or CCB is superior to a thiazide-type diuretic in reducing CVD incidence in racial subgroups. ALLHAT was conducted between February 1994 and March 2002 in 33,357 hypertensive U.S. and Canadian patients aged 55 years or older (35 percent black) with at least 1 other cardiovascular risk factor.

Participants took either a CCB (amlodipine), ACE inhibitor (lisinopril), or a thiazide-type diuretic (chlorthalidone). Other medications were added to achieve goal blood pressures less than 140/90 mm Hg.

The researchers found: "In both racial subgroups as in the whole cohort, neither the ACE inhibitor nor the CCB was more effective than the thiazide-type
'"/>

Contact: George Stamatis
216-368-3635
JAMA and Archives Journals
5-Apr-2005


Page: 1 2

Related medicine news :

1. Diuretics reduce risk of death from congestive heart failure
2. Diuretics effective for people with diabetes and high blood pressure
3. New research brings initial find of Alois Alzheimer to fore once again
4. Recurrence of silent brain lesions after initial stroke may predict subsequent stroke
5. New Orleans toxic soup a less serious problem than initially believed
6. No advantage for four-drug antiretroviral regimen vs. three-drug for initial treatment of HIV-1
7. TB relapse due to low weight gain after initial treatment
8. Most hospitals surveyed do not initially require board certification of pediatricians
9. Study sets new gold standard for initial antiretroviral treatment of HIV infection
10. PRESERVE- 2-year study of initial combo therapy with nateglinide or glyburide + metformin
11. FDA approves new indication for Topamax as initial monotherapy for adults and children with epilepsy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/26/2017)... ... September 26, 2017 , ... Ron Norman, CEO of ... use the Law of Large Numbers in favor of senior, upper-level executive job candidates ... casinos, have long understood the Law of Large Numbers as a way of protecting ...
(Date:9/26/2017)... ... September 26, 2017 , ... CGL Electronic Security Inc., an ... its new umbrella, CGL Technologies, LLC. , The new CGL Technologies, LLC office is ... and Jon McCormack, both of whom have creative business development methods, who are responsive ...
(Date:9/26/2017)... Galloway, N.J. (PRWEB) , ... September 26, 2017 ... ... mocktail at the shore, the John R. Elliott HERO Campaign for Designated Drivers ... Hotel & Golf Club. , Thirty-one local bars and restaurants took on the ...
(Date:9/26/2017)... (PRWEB) , ... September 26, 2017 , ... Founded as ... decades growing into an innovative leader in special education. In 2018, Glenholme will ... , Glenholme, formerly a world renowned horse farm for Hackney show ponies, was generously ...
(Date:9/26/2017)... ... September 26, 2017 , ... The 2017 American Academy of Cosmetic Surgery ... Fat,” revealed not only the latest about cosmetic procedures to remove and replace fat, ... cosmetic medicine. , “Fat really is magical, especially when it comes to the cosmetic ...
Breaking Medicine News(10 mins):
(Date:9/5/2017)... Sapheneia and Scannerside received FDA 510(k) clearance ... a third-party Vendor neutral CT product that makes it ... with current MITA standards. ... is specifically designed to provide CT operators, prior to ... over a predefined threshold. Scannerside Dose Check is intended ...
(Date:9/5/2017)... , Sept. 5, 2017  Getinge, a leading ... a vibrant charitable donation program -- "Color for ... congenital heart defect research by The Children,s Heart ... the general public are encouraged to download a ... the completed artwork to the gallery on the ...
(Date:9/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) (TASE: ... on the development of oral drug delivery systems, announced ... the U.S. Food and Drug Administration (FDA) regarding ORMD-0801, ... At the meeting, the FDA gave ... ORMD-0801, would be a Biologics License Application (BLA).  Such ...
Breaking Medicine Technology:
Cached News: